We also followed up on the unexpected observation that HDACi inhibiting HDAC1/2, but not HDAC3 lead to accumulation of UC cells in G2/M phase, whereas HDACi treatment of many other cancer cell entities—solid and hematopoietic—usually results in G1 arrest [19,20,21,22,23,24,25]. Here, HDAC3 is linked to cancer.